Clinical Trial to study the role of Vistabdhajirna (Indigestion) in Sandhigata Vata (Osteo Arthritis)
- Conditions
- Health Condition 1: M150- Primary generalized (osteo)arthritis
- Registration Number
- CTRI/2021/12/038879
- Lead Sponsor
- ALL INDIA INSTITUTE OF AYURVEDA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1) Presence of Cardinal sign and symptoms of sandhigata Vata and vistabdhajirna along with samanya ajirna lakshana.
2) Digital x-ray depicting the features of osteoarthritis.
3) Patients willing to incorporate themselves in the study.
4)Bone mineral density bmd with T score of -1 or below.
5) Patients who are not receiving any other therapies except the research medicine exclusively for Sandhigata Vata (OA).
1) Severe cases of osteoarthritis as leading to stiffness and immobility.
2) Patients of sandhigata Vata without symptoms of vistabdhajirna or without giving the history of vistabdhajirna.
3) Any other conditions of the joints and bones like Rheumatoid arthritis and Ankylosing Spondylitis, Tubercular arthritis or infective Arthritis will be excluded.
4) Any malignant condition of the body.
5) Systemic diseases like Diabetes mellitus, Hypothyroidism, Chronic Renal Failure etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to assess the change in WOMAC Scale for Osteo Arthritis and Parameters assessment scale for Sandhigata vata, at the end of 90 days of drug intervention.Timepoint: at baseline and after 90 days of intervention
- Secondary Outcome Measures
Name Time Method Radiological changes through X-Ray, BMD score changes <br/ ><br> Changes in Advanced Glycation End Product Assessment through ELISA- quantitative method. <br/ ><br>Timepoint: at baseline and after 90 days of intervention <br/ ><br>